Literature DB >> 15852408

Neurocognitive complications after coronary artery bypass surgery.

Ola A Selnes1, Guy M McKhann.   

Abstract

Both short- and long-term cognitive changes continue to occur after coronary artery bypass grafting (CABG), but the pathophysiology of these neurobehavioral changes remains incompletely understood. The persistence of mild postoperative neurocognitive changes despite multiple improvements in the cardiopulmonary bypass procedure may be partially because of surgical populations being older and having more prevalent comorbid disease. The cause of the early postoperative changes is most likely multifactorial and may include ischemic injury from microemboli, hypoperfusion, and other factors resulting from major surgery. Several lines of evidence suggest that the late cognitive decline between 1 and 5 years after surgery may be secondary to high rates of cerebrovascular disease among candidates for CABG. A history of hypertension and other risk factors for vascular disease is known to be associated with increased risk for long-term cognitive decline in community-dwelling elderly individuals. Cerebrovascular risk factors are also associated with silent magnetic resonance imaging abnormalities in patients undergoing CABG. Thus, whereas both short- and long-term postoperative cognitive changes have been associated with CABG, only the short-term, transient changes appear to be directly related to the use of cardiopulmonary bypass.

Entities:  

Mesh:

Year:  2005        PMID: 15852408     DOI: 10.1002/ana.20481

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

Review 1.  Molecular approaches to improving general anesthetics.

Authors:  Stuart A Forman
Journal:  Anesthesiol Clin       Date:  2010-12

2.  The benefits of cognitive training after a coronary artery bypass graft surgery.

Authors:  Emilie de Tournay-Jetté; Gilles Dupuis; André Denault; Raymond Cartier; Louis Bherer
Journal:  J Behav Med       Date:  2011-11-09

Review 3.  Neurologic complications of cardiac surgery: current concepts and recent advances.

Authors:  David J Bronster
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

Review 4.  Coronary artery revascularization: past, present, future: part II--newer technologies.

Authors:  Anuj Gupta; James Burke; Alfred Bove
Journal:  Clin Cardiol       Date:  2006-08       Impact factor: 2.882

Review 5.  Review of transcranial Doppler ultrasound to detect microemboli during orthopedic surgery.

Authors:  B S Silbert; L A Evered; D A Scott; S Rahardja; R P Gerraty; P F Choong
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

6.  [Cognitive deterioration after cardiosurgery].

Authors:  N Schwarz; M Schönburg; S Kastaun; T Gerriets; M Kaps
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

7.  Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.

Authors:  Yu-Yo Sun; Yikun Li; Bushra Wali; Yuancheng Li; Jolly Lee; Andrew Heinmiller; Koji Abe; Donald G Stein; Hui Mao; Iqbal Sayeed; Chia-Yi Kuan
Journal:  Stroke       Date:  2015-06-09       Impact factor: 7.914

8.  Preoperative gene expression may be associated with neurocognitive decline after cardiopulmonary bypass.

Authors:  Ashraf A Sabe; Rahul S Dalal; Louis M Chu; Nassrene Y Elmadhun; Basel Ramlawi; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10-14       Impact factor: 5.209

9.  Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

Authors:  Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

Review 10.  The dementia of cardiac disease.

Authors:  Hurmina Muqtadar; Fernando D Testai; Philip B Gorelick
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.